Human clinical trials scheduled
Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ? in the back of the eye ? progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science (IOVS).
The paper, titled Early detection of amyloidopathy in Alzheimer’s mice by hyperspectral endoscopy, builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer’s.
Early detection of Alzheimer’s is critical for two reasons. “First, effective treatments need to be administered well before patients show actual neurological signs,” said author Robert Vince, PhD, of the Center for Drug Design at the University of Minnesota (UMN). “Second, since there are no available early detection techniques, drugs currently cannot be tested to determine if they are effective against early Alzheimer’s disease. An early diagnostic tool like ours could help the development of drugs as well.”
Looking through the eye to see the brain is a key advantage of the new technology. “The retina of the eye is not just ‘connected’ to the brain — it is part of the central nervous system,” said author Swati More, PhD, also of the Center for Drug Design at UMN. While the brain and retina undergo similar changes due to Alzheimer’s disease, “unlike the brain, the retina is easily accessible to us, making changes in the retina easier to observe.”
“We saw changes in the retinas of Alzheimer’s mice before the typical age at which neurological signs are observed,” said More. “The results are close to our best-case scenario for outcomes of this project.”
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- ACRS Soars On RA Trial Data, BHVN Disappoints In Alzheimer's Trial, GRTS Joins COVID-19 Vaccine Raceon January 19, 2021 at 9:38 pm
Today's Daily Dose brings you news about another Alzheimer's disease drug failure, encouraging data of Aclaris' rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 ...
- Drug shows promise in treating Alzheimer’son January 19, 2021 at 7:54 pm
Dr. Hazel Wiley with the Memory Disorder Center at Broward Health North said a small clinical trial showed a reduction in amyloid plaques in the brain, a key component of Alzheimer’s disease.
- Clare Crawley’s Ex-Fiance Benoit Beausejour-Savard Sends Support Amid Mom’s Alzheimer’s Battle, Dale Spliton January 19, 2021 at 3:37 pm
Bachelorette’ alum Clare Crawley got support from her ex-fiance Benoit Beausejour-Savard amid her mom’s Alzheimer’s journey and Dale Moss breakup — details ...
- Summerville Alzheimer's support nonprofit celebrates 25 years of serviceon January 19, 2021 at 11:55 am
Peg Lahmeyer and other members of St. Luke’s Lutheran Church in Summerville started a ministry dedicated to supporting people with Alzheimer's disease and the caregivers who look after ...
- Summerville's Alzheimer's support nonprofit celebrates 25 years of serviceon January 19, 2021 at 11:55 am
Peg Lahmeyer and other members of St. Luke’s Lutheran Church in Summerville started a ministry dedicated to supporting people with Alzheimer's and the caregivers who look after them.
- Biohaven (BHVN) Falls as Troriluzole Fails in Alzheimer's Studyon January 19, 2021 at 7:22 am
Biohaven Pharmaceutical BHVN announced dismal preliminary data from a focused analysis of the top-line co-primary and key secondary endpoints of a phase II/III study evaluating its pipeline candidate ...
- Alzheimer's: New research shows a leap forward in identifying neurons vulnerable to the diseaseon January 19, 2021 at 6:42 am
Alzheimer's disease is a devastating condition that is currently unstoppable and incurable. The main cause of the disease is the loss of neurons and other brain cells in the brain—also know as ...
- Blood test could bring new hope to Alzheimer's clinical trialson January 19, 2021 at 6:14 am
A team of scientists at UCL have found that blood tests measuring the hallmark Alzheimer's protein, b-amyloid (amyloid), could radically reduce the cost of clinical trials and potentially open the ...
- Alzheimer's Association: Recognizing the early warning signs of Alzheimer’son January 19, 2021 at 4:00 am
Recognizing and taking steps to address the warning signs of Alzheimer’s and other dementias can be extremely challenging — especially in the early stages. It’s easy and common to dismiss ...
- Visual arts: Painter responds to mother's battle with Alzheimer's disease with arton January 19, 2021 at 1:10 am
Susanne Dotson's show at Sarah Gormley Gallery in the Short North was inspired by her mother, who died Dec. 20.
via Bing News